MS-N149 · Nutrition · Sleep support · Breast cancer · Randomized trial · Appraised 27 October 2026
Can a food-based, tryptophan-rich meal plan improve sleep during chemotherapy for breast cancer?
Evidence at a glance
- Evidence label: Promising short-term sleep signal; fatigue and subjective insomnia unchanged
- Benefit: In a 50-person randomized study, objective sleep time was longer at weeks 4 and 5 and wakefulness after sleep onset was lower at weeks 2 and 4.
- Certainty: Low. This was one small six-week study; the full text was not available for this appraisal, and benefits were inconsistent across time points and outcomes.
- Risk: Food-based plans are usually low risk, but adequacy, food–drug restrictions and weight maintenance matter during chemotherapy.
What was studied
Fifty women receiving chemotherapy for breast cancer were randomized for six weeks to a meal plan providing more than 3,000 mg/day of tryptophan-rich foods or a control diet without sleep-targeted foods. Wrist actigraphy tracked total, light and deep sleep and wake after sleep onset; fatigue and insomnia severity were assessed before and after.
What the evidence found
Total sleep time favored the intervention at weeks 4 and 5 (P=0.007 and P=0.010), and wake after sleep onset favored it at weeks 2 and 4 (P=0.011 and P=0.035). Deep sleep did not differ (P=0.214). Both groups reported improved insomnia severity without a between-group difference, and fatigue did not improve.
How to interpret it
The signal is about sleep timing and continuity—not tumor response, recurrence or survival. Multiple time-point comparisons, a small sample and abstract-only appraisal raise the risk of chance findings. The intervention was a complete meal plan, not isolated tryptophan, melatonin or a commercial sleep supplement.
Practical safety context
Discuss major dietary changes with the oncology dietitian when appetite, nausea, mucositis, diabetes, kidney disease or weight loss is present. Do not combine concentrated tryptophan or sedating products with serotonergic or sedating medicines without review.
Questions for the care team
- What foods and total calories/protein made up the studied plan?
- Could a food-first plan fit current nausea, appetite, glucose and weight goals?
- If insomnia persists, should cognitive behavioral therapy for insomnia or medical assessment be prioritized?
Funding and conflicts
Funding and conflicts were not verified because this appraisal was limited to the PubMed abstract and publisher abstract. The article was published online April 25, 2026 and in the October 2026 issue.
Sources
Last literature search: 27 October 2026. Record appraisal: 27 October 2026. This page is educational and does not replace individualized medical advice. Symptom, biomarker, immune-marker or nutritional changes must not be interpreted as proof of tumor control, recurrence prevention or longer survival unless those outcomes were directly tested.
